News & Events

B-NDG hIL15 Mice: Where Enhanced Human Immune Reconstitution Fuels NK-Dependent Therapies
B-NDG hIL15 Mice: Where Enhanced Human Immune Reconstitution Fuels NK-Dependent Therapies

Highly immunodeficient mouse models enable human immune system reconstitution, allowing the engraftment of human tissues or cells for research on immune function, therapeutic efficacy, and…

Read more
Humanized TL1A Mice for IBD Research
TL1A Pathway: Embarking on New Frontiers in IBD Therapy with Biocytogen’s Humanized Mice

On December 17, Sanofi’s TL1A antibody, duvakitug, demonstrated success in a Phase IIb study, improving clinical remission rates in patients with moderate to severe ulcerative…

Read more
Join BIOCYTOGEN at IMMUNOLOGY (AAI) 2025

We’re thrilled to announce that Biocytogen will be showcasing our innovations at IMMUNOLOGY (AAI) 2025! Join us May 4–6 in beautiful Honolulu, Hawaii, for this…

Read more
Behind the Scenes: Nishit’s Story: From Passionate Foodie to Innovator at Biocytogen

Meet Nishit, a passionate foodie and biking enthusiast who brings his vibrant energy to everything he does, both personally and professionally. Whether he’s exploring Boston’s…

Read more
Biocytogen's humanized and severely immunodeficient mice targeting IL-2, IL-15, and their receptor pathways
IL-2 & IL-15 Pathways: Charting a Bold Frontier in Oncology and Autoimmune Therapies with Biocytogen’s Advanced Mouse Models

The immune system is a complex network orchestrated by cytokines, which act as critical mediators of immune responses. Among them, IL-2 and IL-15, key members…

Read more
Join BIOCYTOGEN at Stanford Drug Discovery Symposium 2025

We’re excited to share that Biocytogen will be exhibiting at the Stanford Drug Discovery Symposium 2025! Mark your calendars for April 28–29 in Stanford, CA,…

Read more
Join BIOCYTOGEN at Bio EU Spring 2025

We’re pleased to share that we will be exhibiting at BIO-Europe Spring 2025! Scheduled from March 17th to 19th in Milan, Italy, this prestigious event…

Read more
Join BIOCYTOGEN at World ADC London 2025

We’re excited to announce our participation as an exhibitor at World ADC London Showcase 2025! From March 3rd to 6th in London, UK, this leading…

Read more
COPD-Related Renbiologics Assets at Biocytogen
COPD in Focus: Current Challenges and New Horizons in Treatment with Biocytogen’s Antibody Innovation

Chronic obstructive pulmonary disease (COPD) is a debilitating respiratory condition that affects millions of lives worldwide. Characterized by airflow obstruction caused by chronic bronchitis and/or…

Read more
Join BIOCYTOGEN at AACR-NCI-EORTC INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS 2025

We’re thrilled to announce that we’ll be exhibiting at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2025! Join us from April 27th…

Read more
Back to top
WordPress Double Opt-in by Forge12